Aurora Cannabis Inc. (NASDAQ:ACB - Get Free Report) saw some unusual options trading on Wednesday. Investors bought 14,034 call options on the stock. This is an increase of approximately 480% compared to the typical daily volume of 2,420 call options.
Analyst Upgrades and Downgrades
Several research firms recently commented on ACB. Atb Cap Markets raised shares of Aurora Cannabis from a "hold" rating to a "strong-buy" rating in a research note on Wednesday. TD Securities raised shares of Aurora Cannabis to a "strong-buy" rating in a research report on Thursday, December 12th. Finally, TD Cowen assumed coverage on Aurora Cannabis in a report on Wednesday, December 11th. They issued a "buy" rating for the company.
Check Out Our Latest Research Report on ACB
Institutional Investors Weigh In On Aurora Cannabis
Institutional investors have recently added to or reduced their stakes in the stock. Tidal Investments LLC grew its holdings in Aurora Cannabis by 2.7% in the third quarter. Tidal Investments LLC now owns 1,344,321 shares of the company's stock worth $7,905,000 after purchasing an additional 34,988 shares during the last quarter. Cubist Systematic Strategies LLC purchased a new position in Aurora Cannabis during the 2nd quarter worth $50,000. Mackenzie Financial Corp acquired a new position in Aurora Cannabis during the 2nd quarter valued at about $113,000. SBI Securities Co. Ltd. purchased a new stake in Aurora Cannabis in the fourth quarter valued at about $31,000. Finally, Wealthspire Advisors LLC acquired a new stake in Aurora Cannabis in the fourth quarter worth about $149,000. Institutional investors own 47.63% of the company's stock.
Aurora Cannabis Stock Down 3.5 %
Shares of ACB traded down $0.22 during midday trading on Friday, reaching $6.03. 8,729,844 shares of the stock were exchanged, compared to its average volume of 5,163,835. The company has a current ratio of 3.30, a quick ratio of 1.88 and a debt-to-equity ratio of 0.07. The company's 50 day moving average is $4.27 and its two-hundred day moving average is $5.16. The company has a market capitalization of $330.81 million, a P/E ratio of 120.62 and a beta of 1.84. Aurora Cannabis has a 52 week low of $2.84 and a 52 week high of $9.35.
Aurora Cannabis (NASDAQ:ACB - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.06 earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.15. Aurora Cannabis had a net margin of 0.42% and a return on equity of 0.59%. On average, sell-side analysts anticipate that Aurora Cannabis will post -0.1 earnings per share for the current year.
Aurora Cannabis Company Profile
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Recommended Stories
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
